Impax Asset Management Group plc lifted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 0.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 621,909 shares of the semiconductor company’s stock after purchasing an additional 3,494 shares during the quarter. Synopsys comprises approximately 1.8% of Impax Asset Management Group plc’s portfolio, making the stock its 14th biggest position. Impax Asset Management Group plc owned about 0.33% of Synopsys worth $305,510,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of SNPS. Stanley Laman Group Ltd. boosted its stake in shares of Synopsys by 542.9% in the third quarter. Stanley Laman Group Ltd. now owns 12,877 shares of the semiconductor company’s stock valued at $6,353,000 after buying an additional 10,874 shares in the last quarter. Symphony Financial Ltd. Co. raised its position in Synopsys by 4,780.9% in the second quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock worth $20,638,000 after acquiring an additional 39,395 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in Synopsys by 0.4% in the second quarter. Bank of New York Mellon Corp now owns 1,347,887 shares of the semiconductor company’s stock valued at $691,035,000 after acquiring an additional 4,815 shares during the period. Waverton Investment Management Ltd boosted its position in shares of Synopsys by 15.0% during the 2nd quarter. Waverton Investment Management Ltd now owns 578,299 shares of the semiconductor company’s stock worth $296,630,000 after purchasing an additional 75,374 shares in the last quarter. Finally, Angeles Wealth Management LLC purchased a new stake in shares of Synopsys during the 2nd quarter worth $478,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity
In other news, insider Janet Lee sold 250 shares of the business’s stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the transaction, the insider owned 11,959 shares of the company’s stock, valued at $6,338,270. The trade was a 2.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Shelagh Glaser sold 3,657 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the transaction, the chief financial officer directly owned 17,842 shares in the company, valued at $8,221,058.34. The trade was a 17.01% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 4,157 shares of company stock valued at $1,945,036 in the last three months. 0.62% of the stock is currently owned by corporate insiders.
Synopsys Price Performance
Synopsys (NASDAQ:SNPS – Get Free Report) last released its quarterly earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The company had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.25 billion. During the same period in the previous year, the firm posted $3.40 earnings per share. The business’s revenue for the quarter was up 37.8% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of equities analysts have recently issued reports on the stock. Morgan Stanley increased their price target on shares of Synopsys from $510.00 to $550.00 and gave the company an “overweight” rating in a report on Friday, December 12th. Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and dropped their target price for the company from $525.00 to $500.00 in a report on Monday, December 8th. Weiss Ratings reiterated a “hold (c)” rating on shares of Synopsys in a research report on Thursday, January 22nd. Citigroup began coverage on Synopsys in a report on Monday, November 24th. They issued a “buy” rating and a $580.00 price target on the stock. Finally, KeyCorp raised their price objective on Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a research note on Thursday, December 11th. Nine analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $553.57.
View Our Latest Report on Synopsys
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
- Five stocks we like better than Synopsys
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
